Impact of Insulin Bolus Reduction on Postprandial Blood Glucose Variations During Continuous and Intermittent Exercise in Patients with Type 1 Diabetes
Not Applicable
- Conditions
- Nutritional, Metabolic, Endocrine
- Registration Number
- PACTR202304590853621
- Lead Sponsor
- repsss
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
age = 18 years
heterogeneous sex (women and men),
duration of diabetes = 1 year,
using multiple daily injections (MDI) for a least 3 months,
HbA1c result (less than 2 months) = 12% (108 mmol/mol).
Exclusion Criteria
presence of clinically significant microvascular complications: nephropathy (glomerular filtration rate <40 ml/min), neuropathy (gastroparesis specifically), or proliferative retinopathy, recent macrovascular events (<3 months), anemia or other abnormal blood test results,
pregnancy,
recent severe hypoglycemia (<2 weeks) ,
a medical situation that could interfere with the protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in plasma glucose levels during exercise (difference between glucose levels at the beginning of the exercise and the lowest glucose levels from the start of the exercise until the end of exercise).<br>
- Secondary Outcome Measures
Name Time Method